Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Tamibarotene

EU orphan designation number: EU/3/18/2053   
Active ingredient: Tamibarotene
Indication: Treatment of acute myeloid leukaemia
Sponsor: Lakeside Regulatory Consulting Services Ltd
20 Lakeside, Aylesbury, Bucks HP19 0FX, United Kingdom

  

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
4/08/2018 Orphan designation EMA/OD/026/18 (2018)5285 of 31/07/2018